Influence of BAK-Preserved Prostaglandin Analog Treatment on the Ocular Surface Health in Patients with Newly Diagnosed Primary Open-Angle Glaucoma

<table>Mean ocular surface disease index (OSDI) of newly diagnosed POAG patients assessed at baseline and after 3 months.</table>

BioMed Research International

fig2

Figure 2

Figure 2: Influence of BAK-Preserved Prostaglandin Analog Treatment on the Ocular Surface Health in Patients with Newly Diagnosed Primary Open-Angle Glaucoma 

Figure 2 | Influence of BAK-Preserved Prostaglandin Analog Treatment on the Ocular Surface Health in Patients with Newly Diagnosed Primary Open-Angle Glaucoma 